Results 51 to 60 of about 13,333,549 (330)

Primary or secondary sicca complex? Investigation in primary biliary cirrhosis by histocompatibility testing.

open access: yesBritish medical journal, 1980
aortocoronary bypass grafts were performed. He was symptom free at followup. (3) A 59-year-oild nan was referred with exertional angina and a soft ejection systolic murmur. His chest radiograph was normal; the ECG showed lateral T wave inversion. Cardiac
A. Hamlyn, D. Adams, S. Sherlock
semanticscholar   +1 more source

Overview of Human Leukocyte Antigen Development at Siriraj Hospital

open access: yesSiriraj Medical Journal, 2017
The International Histocompatibility Workshops and Conferences (IHWC)1 date back to 1964, when D.B. Amos organized the first workshop. The following workshops were held in 1965, 1967, 1970, 1972, 1975, 1977, 1980, 1984, 1987, 1991 and 1996.
Dasnayanee Chandanayingyong
doaj   +1 more source

Imputing amino acid polymorphisms in human leukocyte antigens. [PDF]

open access: yesPLoS ONE, 2013
DNA sequence variation within human leukocyte antigen (HLA) genes mediate susceptibility to a wide range of human diseases. The complex genetic structure of the major histocompatibility complex (MHC) makes it difficult, however, to collect genotyping ...
Xiaoming Jia   +7 more
doaj   +1 more source

Prozone phenomenon in pretransplant testing: An interesting conundrum involving solid-phase and cell-based assays

open access: yesAsian Journal of Transfusion Science, 2022
BACKGROUND: Human leukocyte antigen (HLA) is a major determinant in deciding upon solid organ histocompatibility. Donor-specific anti-HLA antibodies (Donor-specific anti-HLA antibodies (DSAs)) are always a contraindication for solid organ transplantation,
Parvind Singh   +7 more
doaj   +1 more source

Mechanism of remodeling and local effects in vivo of a new injectable cosmetic filler

open access: yesScientific Reports, 2023
By studying the local effects of a new type of injectable cosmetic filler implanted into the animal to explore the mechanism of remodeling and cosmetic effect of this kind of product.
Likui Sun   +6 more
doaj   +1 more source

The history and evolution of HLA typing external proficiency testing schemes in UK NEQAS for H&I

open access: yesFrontiers in Genetics, 2023
The UK National External Quality Assessment Service (NEQAS) provide an external proficiency testing (EPT) service for clinical laboratories. UK NEQAS for Histocompatibility and Immunogenetics (H&I) has been providing EPT schemes for over 45 years and
A. De’Ath, M. T. Rees, D. Pritchard
doaj   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi   +3 more
wiley   +1 more source

Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development

open access: yesNefrología (English Edition), 2017
Introduction: Steroid withdrawal in renal transplantation is desirable to avoid their adverse effects. However, by decreasing the immunosuppression, could lead to an increased risk for the development of HLA-Abs.
Elena Monfá   +9 more
doaj   +3 more sources

Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia

open access: yesMolecular Oncology, EarlyView.
CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy